Sleep Medication Market Expected to Achieve 8% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Sleep Medication Market Size By 2025?
The market size of sleep medication has been on a robust growth trajectory in recent years. It is anticipated to expand from $23.94 billion in 2024 to $25.92 billion in 2025, marking a compound annual growth rate (CAGR) of 8.3%. The historical growth has been driven primarily by factors such as heightened use of prescription sleep aids, an increase in chronic diseases impacting sleep, escalating mental health issues, growing demand for over-the-counter sleep remedies, and the progressive adoption of digital health and telemedicine.

How Big Is the Sleep Medication Market Size Expected to Grow by 2029?
The market size for sleep medication is anticipated to exhibit robust growth over the coming years, expanding to $35.3 billion by 2029 with a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this projected expansion during the forecast period include the mounting adoption of personalized medicine, increased funding in sleep disorder research, heightened awareness driven by digital health platforms, rising demand for natural and herbal sleep inducers, along with a surge in sleep apnea and related disorders. The industry trends, predicting the course of the forecast period, encompass advancements in technologies for drug delivery, improved formulation techniques for extended-release sleep stimulants, the evolution of wearable devices for sleep monitoring, innovative digital tools based on cognitive behavioral therapy, and the emergence of combined therapies addressing sleep disorders.

View the full report here:
https://www.thebusinessresearchcompany.com/report/sleep-medication-global-market-report

Which Key Market Drivers Powering Sleep Medication Market Expansion and Growth?
The growth of the sleep medication market is anticipated to be fueled by the rising occurrence of mental health disorders. These disorders encapsulate a myriad of conditions that influence an individual's mood, thought processing, behaviour, and overall functionality. There is an uptick in mental health problems due to escalating chronic stress levels, which interfere with brain function and exacerbate or induce underlying psychiatric conditions. Sleep medication assists in mitigating these effects by enhancing sleep quality, which is typically disrupted in these disorders. It helps in regulating the sleep and wake cycle, curtailing symptoms such as insomnia and anxiety, and in turn, boosts overall mental wellbeing and daily functioning. For instance, data from the National Institute of Mental Health, a federal government research body in the US, revealed that in 2022, 59.3 million adults aged 18 and above suffered from mental illness, representing 23.1% of the total adult population in the country. Consequently, the escalating incidence of mental health disorders bolsters the sleep medication market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24702&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Sleep Medication Market?
Leading players in the sleep medication market are prioritising the creation of novel products like dual orexin receptor antagonists (DORAs) that offer more precise treatments for insomnia with fewer consequences and a lower risk of dependency. DORAs belong to a category of sleep drugs that target insomnia by blocking the orexin neuropeptides chemicals that induce alertness via the suppression of both orexin receptors (OX1R and OX2R), consequently aiding in sleep-wake cycle regulation. For example, in January 2022, Idorsia Pharmaceuticals Ltd, a pharmaceutical company headquartered in Switzerland, was granted approval from the U.S. Food and Drug Administration (FDA) for the usage of QUVIVIQ (daridorexant) 25mg and 50mg to treat adult insomnia patients. It is a dual orexin receptor antagonist (DORA) that functions by preventing the binding of the wakefulness-inducing neuropeptides orexins, thus helping to regulate the sleep-wake cycle without making the brain drowsy.

What Are the Emerging Segments in the Sleep Medication Market?
The sleep medication market covered in this report is segmented -

1) By Type: Prescription-Based Drugs, Over-The-Counter (OTC) Drugs
2) By Sleep Disorder Type: Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking, Other Sleep Disorders
3) By Drug Class, Benzodiazepines: Antidepressants, Antihistamines, Sedating Antipsychotics, Other Drug Classes
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-Users: Hospitals, Homecare, Speciality Centres, Other End-Users

Subsegments:
1) By Prescription-Based Drugs: Benzodiazepines, Non-Benzodiazepine Hypnotics, Melatonin Receptor Agonists, Orexin Receptor Antagonists, Antidepressants, Antipsychotics, Antihistamines
2) By Over-The-Counter (OTC) Drugs: Antihistamines, Melatonin Supplements, Herbal Supplements, Dietary Supplements, Homeopathic Remedies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24702&type=smp

Who Are the Global Leaders in the Sleep Medication Market?
Major companies operating in the sleep medication market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Perrigo Company plc, H. Lundbeck A/S, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Vanda Pharmaceuticals Inc., Natrol LLC

Which are the Top Profitable Regional Markets for the Sleep Medication Industry?
North America was the largest region in the sleep medication market in 2024. The regions covered in the sleep medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24702

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.